At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
06185 CANSINOBIO
Closed 09-03 16:08:21
29.400
+0.860
+3.01%
High29.820Low28.340Vol5.97M
Open28.440D1 Closing28.540Amplitude5.19%
Mkt Cap7.26BTradable Cap3.90BTotal Shares247.04M
T/O173.77MT/O Rate4.50%Tradable Shares132.67M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
CanSino Biologics' Global Revenue Soars 4,724% in First Half, Systemic Expansion Strategy Unlocks Growth Potential
Deep News  ·  09-02 21:10
CanSino Biologics' Global Revenue Soars 4,724% in First Half, Systemic Expansion Strategy Unlocks Growth Potential
AH Premium Rankings for September 2nd Market Close
Stock News  ·  09-02 16:21
AH Premium Rankings for September 2nd Market Close
Movement Alert｜CANSINOBIO Rises 7.93% in Regular Trading, CLSA Maintains Outperform Rating with 56% Upside Potential
Market Focus  ·  09-02 09:36
Movement Alert｜CANSINOBIO Rises 7.93% in Regular Trading, CLSA Maintains Outperform Rating with 56% Upside Potential
AH Share Premium Rankings for September 1st
Stock News  ·  09-01 16:24
AH Share Premium Rankings for September 1st
CanSino Biologics Inc. Just Missed Earnings - But Analysts Have Updated Their Models
Simply Wall St.  ·  09-01 06:24
CanSino Biologics Inc. Just Missed Earnings - But Analysts Have Updated Their Models
AH Share Premium Report: August 31 Market Close
Stock News  ·  08-31 16:21
AH Share Premium Report: August 31 Market Close
CanSino Leads HK-Listed Vaccine Makers Lower as BioNTech Halts mRNA Trial
Reuters  ·  08-31
CanSino Leads HK-Listed Vaccine Makers Lower as BioNTech Halts mRNA Trial
Movement Alert｜CANSINOBIO Falls 5.48% in Regular Trading, Profit-Taking Continues After Multiple Catalysts Drove Sharp Rally
Market Focus  ·  08-31
Movement Alert｜CANSINOBIO Falls 5.48% in Regular Trading, Profit-Taking Continues After Multiple Catalysts Drove Sharp Rally
AH Premium Rankings for August 28: NE Electric Leads, CATL Records Negative Premium
Stock News  ·  08-28
AH Premium Rankings for August 28: NE Electric Leads, CATL Records Negative Premium
Movement Alert｜CANSINOBIO Falls 5.4% in Regular Trading, Profit-Taking Continues After Multi-Catalyst Rally and H1 Results Release
Market Focus  ·  08-28
Movement Alert｜CANSINOBIO Falls 5.4% in Regular Trading, Profit-Taking Continues After Multi-Catalyst Rally and H1 Results Release
CanSinoBIO Posts 46% Revenue Growth and Near-Break-Even First-Half Result, Boosted by Meningococcal and Pneumococcal Vaccines
Bulletin Express  ·  08-27
CanSinoBIO Posts 46% Revenue Growth and Near-Break-Even First-Half Result, Boosted by Meningococcal and Pneumococcal Vaccines
AH Premium Rankings for August 27: A Market Overview
Stock News  ·  08-27
AH Premium Rankings for August 27: A Market Overview
Movement Alert｜CANSINOBIO Declines 5.04% in Regular Trading, Pullback Continues After mRNA Cooperation-Fueled Surge
Market Focus  ·  08-27
Movement Alert｜CANSINOBIO Declines 5.04% in Regular Trading, Pullback Continues After mRNA Cooperation-Fueled Surge
CanSino Biologics, deepGeneAI Agree to Develop Personalized mRNA Cancer Vaccines
MT Newswires Live  ·  08-26
CanSino Biologics, deepGeneAI Agree to Develop Personalized mRNA Cancer Vaccines
Morning Market Wrap: Hong Kong Shares Rise 0.68% as Copper Stocks Take the Lead
Stock News  ·  08-26
Morning Market Wrap: Hong Kong Shares Rise 0.68% as Copper Stocks Take the Lead
HK Biotech Shares Surge as CansinoBio Jumps Over 18%
Deep News  ·  08-26
HK Biotech Shares Surge as CansinoBio Jumps Over 18%
Movement Alert｜CANSINOBIO Rises 14.34% in Regular Trading, Strategic mRNA Tumor Vaccine Partnership with Depushi Bio Announced
Market Focus  ·  08-26
Movement Alert｜CANSINOBIO Rises 14.34% in Regular Trading, Strategic mRNA Tumor Vaccine Partnership with Depushi Bio Announced
Movement Alert｜CANSINOBIO Rises 6.15% in Regular Trading, Rebounding After Multi-Day Pullback as Broker Flags Severe Undervaluation in mRNA Sector
Market Focus  ·  08-25
Movement Alert｜CANSINOBIO Rises 6.15% in Regular Trading, Rebounding After Multi-Day Pullback as Broker Flags Severe Undervaluation in mRNA Sector
AH Share Premium Rankings: Market Close Update for August 24
Stock News  ·  08-24
AH Share Premium Rankings: Market Close Update for August 24
Movement Alert｜CANSINOBIO Declines 5.16% in Regular Trading, Profit-Taking Continues After mRNA-Driven Surge
Market Focus  ·  08-24
Movement Alert｜CANSINOBIO Declines 5.16% in Regular Trading, Profit-Taking Continues After mRNA-Driven Surge

Introduction

Company Name.
CANSINOBIO
Affiliated Markets:
SEHK
Listing Date:
--
Main Business:
CanSino Biologics Inc is a clinical-stage vaccine company in China. The Company's products include Ad5-EBOV vaccine used for Ebola virus, MCV2 and MCV4 vaccines for meningococcus, PBPV vaccine used for pneumococcal and the recombinant novel coronavirus vaccine. Its products are mainly used in meningitis, diphtheria pertussis tetanus (DPT) and pneumonia.
Issue price:
--